IRIS Accounts Production v24.3.2.46 10627503 Board of Directors 1.8.23 31.7.24 31.7.24 0 0 false true false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh106275032023-07-31106275032024-07-31106275032023-08-012024-07-31106275032022-07-31106275032022-08-012023-07-31106275032023-07-3110627503ns15:EnglandWales2023-08-012024-07-3110627503ns14:PoundSterling2023-08-012024-07-3110627503ns10:Director12023-08-012024-07-3110627503ns10:PrivateLimitedCompanyLtd2023-08-012024-07-3110627503ns10:SmallEntities2023-08-012024-07-3110627503ns10:AuditExempt-NoAccountantsReport2023-08-012024-07-3110627503ns10:SmallCompaniesRegimeForDirectorsReport2023-08-012024-07-3110627503ns10:SmallCompaniesRegimeForAccounts2023-08-012024-07-3110627503ns10:FullAccounts2023-08-012024-07-3110627503ns10:Director22023-08-012024-07-3110627503ns10:RegisteredOffice2023-08-012024-07-3110627503ns5:CurrentFinancialInstruments2024-07-3110627503ns5:CurrentFinancialInstruments2023-07-3110627503ns5:Non-currentFinancialInstruments2024-07-3110627503ns5:Non-currentFinancialInstruments2023-07-3110627503ns5:ShareCapital2024-07-3110627503ns5:ShareCapital2023-07-3110627503ns5:RetainedEarningsAccumulatedLosses2024-07-3110627503ns5:RetainedEarningsAccumulatedLosses2023-07-3110627503ns5:CostValuation2023-07-3110627503ns5:WithinOneYearns5:CurrentFinancialInstruments2024-07-3110627503ns5:WithinOneYearns5:CurrentFinancialInstruments2023-07-3110627503ns5:Secured2024-07-3110627503ns5:Secured2023-07-31106275031ns10:Director12023-07-31106275031ns10:Director12022-07-31106275031ns10:Director12023-08-012024-07-31106275031ns10:Director12022-08-012023-07-31106275031ns10:Director12024-07-31106275031ns10:Director12023-07-3110627503ns10:Director222023-07-3110627503ns10:Director222022-07-3110627503ns10:Director222023-08-012024-07-3110627503ns10:Director222022-08-012023-07-3110627503ns10:Director222024-07-3110627503ns10:Director222023-07-31
REGISTERED NUMBER: 10627503 (England and Wales)












Unaudited Financial Statements

for the Year Ended 31 July 2024

for

RPMR Healthcare Limited

RPMR Healthcare Limited (Registered number: 10627503)






Contents of the Financial Statements
for the Year Ended 31 July 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


RPMR Healthcare Limited

Company Information
for the Year Ended 31 July 2024







DIRECTORS: Mr R M Pitt
Mr M D Roberts





REGISTERED OFFICE: 6 Neville Parade
Newton Aycliffe
Co. Durham
DL5 5DH





REGISTERED NUMBER: 10627503 (England and Wales)





ACCOUNTANTS: S&W Partners (Newcastle) Limited
17 Queens Lane
Newcastle upon Tyne
Tyne and Wear
NE1 1RN

RPMR Healthcare Limited (Registered number: 10627503)

Balance Sheet
31 July 2024

2024 2023
Notes £    £   
FIXED ASSETS
Investments 5 2,417,438 2,417,438
Investment property 6 201,899 201,899
2,619,337 2,619,337

CURRENT ASSETS
Debtors 7 84,377 82,640
Cash at bank 1,146 512
85,523 83,152
CREDITORS
Amounts falling due within one year 8 (1,936,494 ) (1,754,261 )
NET CURRENT LIABILITIES (1,850,971 ) (1,671,109 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

768,366

948,228

CREDITORS
Amounts falling due after more than one
year

9

(1,194,634

)

(1,317,560

)
NET LIABILITIES (426,268 ) (369,332 )

CAPITAL AND RESERVES
Called up share capital 100 100
Profit and loss account (426,368 ) (369,432 )
(426,268 ) (369,332 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24 April 2025 and were signed on its behalf by:





Mr R M Pitt - Director


RPMR Healthcare Limited (Registered number: 10627503)

Notes to the Financial Statements
for the Year Ended 31 July 2024

1. STATUTORY INFORMATION

RPMR Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Preparation of consolidated financial statements
The financial statements contain information about RPMR Healthcare Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover consists of rents receivable in regard to the company's investment property.

Investments in subsidiaries
Investments in subsidiaries are recognised at cost less impairment.

Investment property
Investment property is shown at fair value. Any aggregate surplus or deficit arising from changes in fair value
is recognised in profit or loss.

Impairment of assets
At each reporting date assets are reviewed to determine whether there is any indication that those assets have suffered an impairment loss. If there is an indication of possible impairment, the recoverable amount of any affected asset is estimated and compared with its carrying amount. If estimated recoverable amount is lower, the carrying amount is reduced to its estimated recoverable amount, and an impairment loss is recognised immediately in profit or loss.

If an impairment loss subsequently reverses, the carrying amount of the asset is increased to the revised estimate of its recoverable amount, but not in excess of the amount that would have been determined had no impairment loss been recognised for the asset in prior years. A reversal of an impairment loss is recognised immediately in profit or loss.

Financial instruments
The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties, loans to related parties and investments on non-puttable ordinary shares.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


RPMR Healthcare Limited (Registered number: 10627503)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2024

3. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

5. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 August 2023
and 31 July 2024 2,417,438
NET BOOK VALUE
At 31 July 2024 2,417,438
At 31 July 2023 2,417,438

6. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 August 2023
and 31 July 2024 201,899
NET BOOK VALUE
At 31 July 2024 201,899
At 31 July 2023 201,899

The fair value of the property at 31 July 2024 has been arrived at on the basis of a valuation carried out by the directors, who are not professionally qualified valuers. The valuation, was arrived at by reference to market evidence of transaction prices for similar properties in its location.

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Other debtors 84,377 82,640

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 85,918 85,918
Amounts owed to group undertakings 1,323,696 1,104,816
Amounts owed to associated companies 523,568 561,746
Taxation and social security 1,486 581
Other creditors 1,826 1,200
1,936,494 1,754,261

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Bank loans 1,194,634 1,317,560

RPMR Healthcare Limited (Registered number: 10627503)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2024

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR - continued
2024 2023
£    £   
Amounts falling due in more than five years:

Repayable by instalments
Bank loans 850,962 973,888

10. SECURED DEBTS

The following secured debts are included within creditors:

2024 2023
£    £   
Bank loans 1,280,552 1,403,478

The bank loans are secured by a fixed and floating charge over the assets of the company and also contains a negative pledge.

11. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 July 2024 and 31 July 2023:

2024 2023
£    £   
Mr R M Pitt
Balance outstanding at start of year 25,455 24,946
Amounts advanced 636 509
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 26,091 25,455

Mr M D Roberts
Balance outstanding at start of year 26,516 25,986
Amounts advanced 663 530
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 27,179 26,516

The above advances are made at an interest rate of 2% and are repayable on demand.